Discover What’s Next for Precision Medicine in IBD in 2026
The 4th Precision Medicine in Inflammatory Bowel Disease Summit 2026 is the definitive meeting uniting the brightest minds in Pharma, Biotech and Research to accelerate the next generation of personalized therapies for Crohn’s and Ulcerative Colitis.
As the IBD field enters a new era of multiomic integration, AI-driven discovery and biomarker-powered precision care, this is your chance to join the innovators breaking through disease complexity and transforming patient outcomes.
Across two immersive workshop sessions and two days of cutting-edge content, you’ll explore how combination therapy design, advanced diagnostics, artificial intelligence and novel preclinical models are reshaping how IBD is understood and treated.
Expect an agenda packed with actionable insights, interactive discussions, and unparalleled networking opportunities with senior biopharma leaders actively driving partnership, investment, and innovation in IBD precision medicine.
Join this exclusive community of scientific and strategic pioneers, and be part of the movement redefining the future of IBD therapy.
Unmissable Event Highlights:
Interactive AI Workshop
Build and test machine learning models in a live, follow-along tutorial using real IBD datasets to predict treatment response and explore practical applications of AI in drug development.
Hands-On Learning from Experts
Gain actionable insights from Takeda, Locus Biosciences, Spyre Therapeutics, and Abbvie exploring breakthroughs that accelerate preclinical validation and enhance biomarker-driven precision therapies.
Combination Therapy Deep-Dive
Learn strategies to optimize patient selection, integrate anti-inflammatory and anti-fibrotic approaches, and design adaptive trials to improve response rates and extend remission.
What's New for 2026?
New Industry Leaders Presenting
2026 brings innovative biotech such as Locus Biosciences and big pharma voices from J&J to the stage, ensuring fresh perspectives on precision medicine, combination therapies, and next-generation diagnostics.
Enhanced Combination Therapy Focus
New breakout content on targeting multiple disease pathways simultaneously, including integrating anti-fibrotic and anti-inflammatory approaches for personalized patient care.
Broader Networking Opportunities
More curated networking sessions, including interactive roundtables, speed networking, and dedicated time with senior biopharma executives actively advancing IBD pipelines.
Explore the Full Event Guide
- 70+ senior biopharma leaders driving precision innovation
- 2 deep-dive workshop sessions covering artificial intelligence and combination therapy design
- Exclusive insights into cutting-edge organoid, multiomic, and computational models
- Unparalleled networking opportunities with decision-makers advancing IBD pipelines
- Discover breakthrough strategies shaping the next generation of personalized care
Attending Companies Include
Explore the Agenda
Discover cutting-edge sessions on AI, biomarkers, and combination therapies redefining IBD precision medicine.
Partner With Us
Connect with senior biopharma leaders seeking innovative tools, models, and data solutions to advance IBD pipelines.
Join Biopharma Experts
Network with industry pioneers shaping the next generation of personalized Crohn’s and Colitis treatments.